What is Hemangeol, and what dose schedule is used?
Hemangeol (propranolol oral solution) is used to treat infantile hemangioma. Dosing is weight-based and built around a titration schedule followed by maintenance dosing. The usual approach is to start low, increase gradually every few days, and then keep the dose steady at the target amount. Specific dosing for individual infants depends on weight and the exact product strength and instructions from the prescribing clinician.
Because dosing must be matched to the infant’s weight and ramped up safely, the most accurate schedule is the one in the official prescribing information for your Hemangeol product and strength.
How do you calculate Hemangeol dose by weight?
Hemangeol dosing is calculated using the infant’s body weight (kg). The clinician converts weight into the total daily propranolol dose, then divides that daily dose into the required number of administrations per day per the label instructions (typically as multiple doses rather than once daily). During the ramp-up period, the per-dose amount increases gradually until the target dose level is reached.
If you share your infant’s weight (kg) and the Hemangeol bottle strength on the label, I can help you map that weight to the dosing steps described by the label.
When should Hemangeol be given (with food, and how many times a day)?
Hemangeol dosing is designed around feeding to reduce the risk of low blood sugar (hypoglycemia). That means doses are taken with meals or immediately after feeding, and spaced according to the labeled schedule (multiple doses daily). Skipping meals or giving doses when the infant is not feeding can increase risk.
How long is treatment, and when do doses change?
Treatment usually runs for a defined total course length in months, with the early phase involving dose escalation to reach the target dose. Once the target dose is reached, dosing typically remains at that level for the remainder of the course unless the clinician adjusts for side effects, changes in weight, or other clinical reasons.
The exact start date, escalation timing, total planned duration, and any adjustments should come from the prescribing clinician’s plan and the product label.
What side effects should parents watch for during Hemangeol dosing?
Common concerns during propranolol treatment in infants include:
- Low blood sugar symptoms (for example, unusual sleepiness, poor feeding, shakiness, sweating, or lethargy), especially if a feeding is missed.
- Slower heart rate or low blood pressure symptoms (for example, unusual fatigue or dizziness in older infants).
- Bronchospasm/wheezing (in infants who are prone to respiratory issues).
- Vomiting or feeding intolerance.
Clinicians often advise monitoring and provide clear “what to do if” instructions. If your infant has symptoms that suggest hypoglycemia, breathing trouble, or marked sleepiness, seek urgent medical guidance.
What happens if a dose is missed or treatment needs to be adjusted?
If a dose is missed, the plan is usually not to “double up.” Instead, you follow the instructions given in the prescribing information or your clinician’s directions for resuming the schedule. If the infant vomits soon after a dose, the clinician may advise whether to repeat the dose or wait until the next scheduled administration.
If weight changes significantly during therapy, the dose often needs recalculation to keep the mg/kg dose consistent.
Are there situations where Hemangeol dosing should be changed or avoided?
Dosing requires extra caution or may be paused/adjusted in certain conditions such as:
- Feeding problems or inability to take regular feeds.
- Intercurrent illness (especially with reduced intake).
- Respiratory issues like wheezing.
- Certain heart rhythm or blood pressure problems.
Your prescribing clinician should screen for contraindications and determine whether any baseline testing or in-clinic dose escalation is needed.
---
Quick follow-up so I can give the exact dosing schedule
What is the infant’s weight (kg) and the Hemangeol bottle strength shown on your label (e.g., mg/mL)? Also, is this the start of therapy (dose ramp-up) or already at a target dose?